FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company Profile908 Devices Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MASS
908 Devices Inc. Stock AnalysisComprehensive stock analysis for 908 Devices Inc. (MASS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMASS
MASS
908 Devices Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MASS
  1. Home
  2. Stocks
  3. 908 Devices Inc.

908 Devices Inc.

🇺🇸MASS•NASDAQ

908 Devices Inc.

🇺🇸MASS•NASDAQ
Market cap
$360.52M

Your view on MASS

Mkt Cap
$360.52M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About 908 Devices Inc.

Industry
Medical - Specialties
Sector
Healthcare
CEO
Kevin J. Knopp
Headquarters
645 Summer Street, Boston, MA, US
Industry
Medical - Specialties
Sector
Healthcare
CEO
Kevin J. Knopp
Headquarters
645 Summer Street, Boston, MA, US
Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.

It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for 908 Devices Inc.. Starting points for 908 Devices Inc.: EPS -$0.59, beta 0.63 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for 908 Devices Inc.. Trailing twelve-month EPS for 908 Devices Inc. stands at -$0.59. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
Analysts' target$14.00average of analysts' targets
Current price—

Buy

Targets, low to high

$14.00

Low $14.00

Middle $14.00

High $14.00

Analyst ratings

3 firms, last 12 months
  • Strong Buy0
  • Buy3
  • Hold0
  • Sell0
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$0.09−$0.13−$0.82−$0.50
Lowest estimate−$0.10−$0.21−$1.19−$0.78
Highest estimate−$0.09−$0.04−$0.13−$0.02
Number of analysts3233
A year ago−$0.05−$0.221−$0.941—
Growth vs a year ago−84.0%———

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$20.81M$16.29M$69.20M$82.11M
Lowest estimate$20.68M$16.05M$69.07M$81.51M
Highest estimate$20.98M$16.53M$69.37M$82.51M
Number of analysts4355
A year ago$17.38M$13.38M$56.20M—
Growth vs a year ago+19.8%+21.7%+23.1%—
Recent rating and target changes (15)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for 908 Devices Inc.. 908 Devices Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold MASS14 companies · 8 funds
Compare MASS with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AAgilent Technologies, Inc.HealthcareMedical - Diagnostics & Research$48.0B
QGENQiagen N.V.HealthcareMedical - Diagnostics & Research$10.2B
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
NSCIFNanalysis Scientific Corp.HealthcareOTC$12.4M
NYXHNyxoah S.A.HealthcareNASDAQ$82.0M
OIL.AXOptiscan Imaging LimitedHealthcareASX—
OMDDOrmand Industries IncHealthcareOTC$310
OMRXOrthometrix, Inc.HealthcareOTC$4,699
OMWSOmnia Wellness Inc.HealthcareOTC$46,301
PBIOPressure BioSciences, Inc.HealthcareOTC$20,484
PMSNFProteome Sciences plcHealthcareOTC$11.8M
QDELQuidelOrtho CorporationHealthcareNASDAQ$570.9M
SDCCQSmileDirectClub, Inc.HealthcareOTC$13,395
SIShoulder Innovations, Inc.HealthcareNYSE$421.6M
SSMXFSysmex CorporationHealthcareOTC$5.4B
ETFs holding 908 Devices Inc.
TickerFundFund assets% of the fund
ARKGARK Genomic Revolution ETF$2.2B in assets1.09%
AVUVAvantis U.S. Small Cap Value ETF$31.6B in assets0.04%
IWMiShares Russell 2000 ETF$76.6B in assets0.01%
VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
SGRWHarbor Active Small Cap Growth ETF (SGRW)$28M in assets0.94%
FITEState Street SPDR S&P Kensho Future Security ETF$150M in assets0.58%
IWCiShares Micro-Cap ETF$1.2B in assets0.08%
VTWVVanguard Russell 2000 Value ETF$1.3B in assets0.02%

Largest holders first, then the funds most concentrated in MASS.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold 908 Devices Inc., and how their positions are changing. At a $360.5M market value, institutional positions materially move 908 Devices Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by 908 Devices Inc. executives and directors. Shares of 908 Devices Inc. have traded between $1.81 and $9.34 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for 908 Devices Inc.. Coverage tracks 908 Devices Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of 908 Devices Inc.

MASS AnalysisFair
Past
5
Growth
2
Health
5
Profit
1
Value
1